Chemed (CHE) Non-Current Deffered Revenue (2009 - 2026)

Chemed (CHE) has reported Non-Current Deffered Revenue for 18 consecutive years, with $142.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Deffered Revenue rose 12.07% year-over-year to $142.7 million; the TTM figure through Mar 2026 stood at $142.7 million (up 12.07% YoY), while the FY2025 annual figure was $136.1 million, up 8.02% from the prior year.
• Non-Current Deffered Revenue came in at $142.7 million for Q1 2026 at Chemed, up from $136.1 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $142.7 million in Q1 2026, with the low at $89.9 million in Q3 2022.
• Average Non-Current Deffered Revenue over 5 years is $113.7 million, with a median of $117.6 million recorded in 2024.
• Across the five-year window, Non-Current Deffered Revenue retreated 10.49% in 2022 and rose 21.11% in 2024, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $92.3 million in 2022, then advanced by 12.71% to $104.1 million in 2023, then advanced by 21.11% to $126.0 million in 2024, then increased by 8.02% to $136.1 million in 2025, then increased by 4.79% to $142.7 million in 2026.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $142.7 million, $136.1 million, and $132.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.